Cargando…
Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients
CONTEXT: Levothyroxine monotherapy is the treatment of choice for hypothyroid patients because peripheral T4 to T3 conversion is believed to account for the overall tissue requirement for thyroid hormones. However, there are indirect evidences that this may not be the case in all patients. OBJECTIVE...
Autores principales: | Gullo, Damiano, Latina, Adele, Frasca, Francesco, Le Moli, Rosario, Pellegriti, Gabriella, Vigneri, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148220/ https://www.ncbi.nlm.nih.gov/pubmed/21829633 http://dx.doi.org/10.1371/journal.pone.0022552 |
Ejemplares similares
-
Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy
por: Ito, Mitsuru, et al.
Publicado: (2017) -
Proportion of serum thyroid hormone concentrations within the reference ranges in athyreotic patients on levothyroxine monotherapy: a retrospective study
por: Ito, Mitsuru, et al.
Publicado: (2022) -
Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors
por: Pellegriti, Gabriella, et al.
Publicado: (2013) -
The impact of acute hypothyroidism on lipid levels in athyreotic patients
por: Salehidoost, Rezvan, et al.
Publicado: (2012) -
Perfect Density Models Cannot Guarantee Anomaly Detection
por: Le Lan, Charline, et al.
Publicado: (2021)